102 related articles for article (PubMed ID: 17419519)
1. Immunocompetency in children with recurrent respiratory papillomatosis: prospective study.
Stern Y; Felipovich A; Cotton RT; Segal K
Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):169-71. PubMed ID: 17419519
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of serum interleukins in recurrent respiratory papillomatosis: a preliminary study.
Snowden RT; Thompson J; Horwitz E; Stocks RM
Laryngoscope; 2001 Mar; 111(3):404-8. PubMed ID: 11224768
[TBL] [Abstract][Full Text] [Related]
3. 2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis.
Gerein V; Rastorguev E; Gerein J; Lodemann E; Pfister H; Draf W; Desloovere C
J Laryngol Otol; 2004 Oct; 118(10):750-6. PubMed ID: 15550179
[TBL] [Abstract][Full Text] [Related]
4. [Natural killer activity in respiratory papillomatosis and its changes after interferon treatment].
Pritsker AD; Grigorian SS; Onufrieva EK; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):409-11. PubMed ID: 1803776
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immunocompetency in juvenile laryngeal papillomatosis.
Perrick D; Wray BB; Leffell MS; Harmon JD; Porubsky ES
Ann Allergy; 1990 Jul; 65(1):69-72. PubMed ID: 2368934
[TBL] [Abstract][Full Text] [Related]
6. Recurrent respiratory papillomatosis: altered CD8(+) T-cell subsets and T(H)1/T(H)2 cytokine imbalance.
Bonagura VR; Hatam L; DeVoti J; Zeng F; Steinberg BM
Clin Immunol; 1999 Dec; 93(3):302-11. PubMed ID: 10600342
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis.
Rosen CA; Woodson GE; Thompson JW; Hengesteg AP; Bradlow HL
Otolaryngol Head Neck Surg; 1998 Jun; 118(6):810-5. PubMed ID: 9627242
[TBL] [Abstract][Full Text] [Related]
8. [The detection of cytokine and immunoglobulin in sera of children with respiratory papillomatosis].
Xia Z; Yang Z; Guo Y; Wang Z; Xu Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Jun; 16(6):292-4. PubMed ID: 12599783
[TBL] [Abstract][Full Text] [Related]
9. Natural cytotoxicity and interferon production in patients with recurrent respiratory papillomatosis.
Naiman HB; Doyle AT; Ruben RJ; Kadish AS
Ann Otol Rhinol Laryngol; 1984; 93(5 Pt 1):483-7. PubMed ID: 6437314
[TBL] [Abstract][Full Text] [Related]
10. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group.
Leventhal BG; Kashima HK; Mounts P; Thurmond L; Chapman S; Buckley S; Wold D
N Engl J Med; 1991 Aug; 325(9):613-7. PubMed ID: 1861694
[TBL] [Abstract][Full Text] [Related]
11. [The interferon status and circulating immunoglobulins during the interferon therapy of respiratory papillomatosis in children].
Pritsker AD; Grigorian SS; Onufrieva SS; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):411-4. PubMed ID: 1725077
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte profile and cytokine mRNA expression in peripheral blood mononuclear cells of patients with recurrent respiratory papillomatosis suggest dysregulated cytokine mRNA response and impaired cytotoxic capacity.
Holm A; Nagaeva O; Nagaev I; Loizou C; Laurell G; Mincheva-Nilsson L; Nylander K; Olofsson K
Immun Inflamm Dis; 2017 Dec; 5(4):541-550. PubMed ID: 28805308
[TBL] [Abstract][Full Text] [Related]
13. S-phase fraction as a predictor of prognosis in juvenile respiratory papillomatosis.
Stern Y; Mueller K; Willging JP; Myer CM; Cotton RT
Arch Otolaryngol Head Neck Surg; 1998 May; 124(5):541-4. PubMed ID: 9604980
[TBL] [Abstract][Full Text] [Related]
14. Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis.
Bonagura VR; Siegal FP; Abramson AL; Santiago-Schwarz F; O'Reilly ME; Shah K; Drake D; Steinberg BM
Clin Diagn Lab Immunol; 1994 May; 1(3):357-60. PubMed ID: 7496977
[TBL] [Abstract][Full Text] [Related]
15. Significance of DNA ploidy and cell proliferation in juvenile respiratory papillomatosis.
Stern Y; Hurtubise PE; Cotton RT
Ann Otol Rhinol Laryngol; 1998 Oct; 107(10 Pt 1):815-9. PubMed ID: 9794608
[TBL] [Abstract][Full Text] [Related]
16. Recurrent respiratory papillomatosis in children: masquerader of common respiratory diseases.
Zacharisen MC; Conley SF
Pediatrics; 2006 Nov; 118(5):1925-31. PubMed ID: 17079563
[TBL] [Abstract][Full Text] [Related]
17. [The effect of exogenous interferon on the in vitro production of alpha- and gamma-interferon by the lymphocytes of patients with respiratory papillomatosis].
Grigorian SS; Pritsker AD; Onufrieva EK; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):407-9. PubMed ID: 1803775
[TBL] [Abstract][Full Text] [Related]
18. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
Gerein V; Schmandt S; Babkina N; Barysik N; Coerdt W; Pfister H
Cancer Detect Prev; 2007; 31(4):276-81. PubMed ID: 17935912
[TBL] [Abstract][Full Text] [Related]
19. Children and partners of patients with recurrent respiratory papillomatosis have no evidence of the disease during long-term observation.
Gerein V; Soldatski IL; Babkina N; Onufrieva EK; Barysik N; Pfister H
Int J Pediatr Otorhinolaryngol; 2006 Dec; 70(12):2061-6. PubMed ID: 16945430
[TBL] [Abstract][Full Text] [Related]
20. [Structure of immunological defect in laryngeal papillomatosis in children].
Tsvetkov EA; Savenko IV
Vestn Otorinolaringol; 1996; (4):9-11. PubMed ID: 8966886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
